Background. Coronary collaterals develop in response to an ischemic stimulus. However, collateral growth is not sufficient to result in the complete recovery of coronary reserves. Using a porcine model of gradual coronary artery occlusion, we investigated the effect of continuous heparin infusion on coronary collateral development.
vessel remodeling and new vessel synthesis in the bed at risk occur. [5] [6] [7] Studies in dogs have shown that this species possesses an extensive endogenous collateral circulation. The growth of new collateral vessels in the dog after slow coronary artery occlusion is a rapid process8,9 that results in normal blood flow to the region at risk, maintenance of coronary reserves, and reduction of infarct size in the region at risk.10 In contrast, humans and pigs have limited endogenous collateral circulation."-'3 Using a porcine model, we previously have shown that pigs respond to an ischemic stimulus with a rapid burst of collateral development, and al-though the newly synthesized collateral vessels allow the restoration of normal resting blood flow levels after coronary artery occlusion, coronary reserve levels remain severely compromised. 12"14"15 In the past decade, several potent angiogenic agents, including a variety of growth factors, have been described. The usefulness of these factors in facilitating blood vessel growth in the heart is an important field of investigation. Several studies have demonstrated that heparin is a potent angiogenic agent. 16"7 In addition, there is evidence suggesting that administration of heparin in vivo has positive effects on collateral development in the heart. For example, heparin, in conjunction with exercise in humans, increased the level of blood vessel development in patients with stable effort angina. '8-20 Heparin also accelerates collateral growth in dogs subjected to brief repeated coronary occlusion. 2' In addition, Unger and coworkers22 found that after an ischemic stimulus, localized delivery of heparin to a specific vessel increased the proportion of collateral flow originating from that vessel. However, in this canine model, the total amount of collateral flow did not increase. 22 We have developed a porcine model to study the rate of blood vessel growth in response to ischemia. We and others have shown by a variety of methods that angiogenesis occurs in animals in which an ameroid constrictor occludes the left circumflex coronary artery. '2"5'23 In the present study, we examined the effect of constant heparin infusion on collateral development in pigs. Our results suggest that heparin greatly increases the rate of collateral development and facilitates the rapid recovery of coronary reserves.
Methods

Animal Preparation
The animals in this experimental protocol were handled according to the guidelines for animal care of the American Physiology Society. The Animal Subjects Committee of the University of California, San Diego approved this protocol. We sedated the pigs with ketamine (25 mg/kg i.m.), atropine (0.05 mg/kg i.m.), and sodium thialmylal (20 mg/kg i.v.), and then intubated and maintained them on 1% to 2% halothane anesthesia during an aseptic surgical procedure. A left thoracotomy was performed at the fourth intercostal space, and Silastic catheters were placed in the left atrium and proximal descending aorta. The proximal left circumflex coronary artery was dissected free of surrounding tissue for a length of 1 to 1.5 cm. A metal-encased ameroid constrictor with a 1.8-to 2.0-mm lumen (manufactured in this laboratory; material obtained from K.-G. Ulrich, Montreal, Quebec, Canada) was placed around the dissected artery. We selected the ameroid constrictor with the proper luminal dimensions to provide a tight fit to the coronary artery. The lumen was oval rather than circular; this shape allows complete closure of the ameroid in a narrow time window. Occlusion of the vessel occurs gradually as the walls of the artery are pinched together by the swelling ameroid. In contrast with circular constrictors, closure may occur by thrombus formation, resulting in acute occlusion of the vessel. We have used the oval ameroid occluder in 30 
Experimental Groups
Animals were Yucatan minipigs obtained from a local breeder (S&S Farms, Ranchita, Calif). The data for the normal controls (10 pigs) are from a previous study.27 The 16 pigs used in this study were males (average weight, 34±2 kg) and were divided at random into two groups. The first group (eight pigs) had ameroid placement but no pharmaceutical intervention (designated "untreated-ameroid"). The second group (eight pigs) had ameroid placement and continuous heparin infusion (designated "heparin-ameroid"). AIzet osmotic pumps (model 2m1-2, Alza, Inc., Palo Alto, Calif) were loaded with 2 mL of porcine intestinal heparin (60,000 units/mL; Sigma Chemical, St. Louis, Mo) dissolved in phosphate-buffered saline. We installed two pumps in each animal subcutaneously at the time of the initial surgery so that the attached catheter would pump into the external jugular vein. The vein remained patent by using a small purse string attached to a 1-mm vinyl catheter. The pumps were exchanged for new ones at 14 days (after the 14-day study) using thialymlal anesthesia (25 mg/kg i.v.). Heparin perfusion rate was approximately 150 units/h per pump for a total of 300 units/h.
We measured indirectly the amount of heparin infused using the activated partial prothrombin time (APTT) with reagents from Dade (Miami, Fla). In three untreated-ameroid pigs and three heparinameroid pigs, APTT was measured hourly for 24 hours at 12 days after the initial surgery. We obtained blood from carefully flushed arterial catheters that had had no heparin cap for at least 24 hours before the test. In addition, all animals received at least two tests per week administered at random, and three human volunteers had the same tests performed on venous blood samples for comparison.
One animal in the untreated-ameroid group died 9 days after ameroid implantation of the occluder, apparently from ventricular fibrillation, and was excluded from the study. However, examination of the constrictor in the pig that fibrillated revealed that, as expected, the device had occluded the left circumflex coronary artery. These data indicate that the constrictor closed 9 to 11 days after instrumentation (also see below). Experimental Protocols After 14, 21, and 28 days, the variables recorded on an eight-channel ink recorder (model 7848-A, HewlettPackard, Andover, Mass) while the animals stood quietly in a darkened room in the laboratory were aortic pressure, left atrial pressure, and heart rate (using bipolar surface ECG).
We gave six doses of radiolabeled microspheres to pigs at rest or during an infusion of adenosine (1.25 mg * mind -kg-') into the left atrial catheter. Previous results indicated that there is complete vasodilation with this dose27 (also see Fig 1) .
It was important to know the status of the ameroid occluder, especially at the early time points. Four pigs were euthanized at the finish of the 14-day study to see if all the pigs had closed occluders (two in the untreated-ameroid group and two in the heparin-ameroid group). All the pigs had completely occluded left circumflex coronary arteries. Because we used specially designed tightly fitting occluders and because all the pigs euthanized at 14 days plus the one pig that died at 9 days had completely occluded arteries, it is presumed that all the pigs had occluded arteries at the time of the first study. In addition, it was verified that all the pigs had completely occluded left circumflex coronary arteries at the time of euthanasia. the constrictor is ellipsoid, closure results by the gradual pinching together of the artery walls rather than by the acute formation of a thrombus within the vessel (see "Methods"). This model results in small (generally 15% or less) uniform infarcts in the left circumflex coronary artery bed at risk but minimal contractile dysfunction. Blood flow through the remaining coronary arteries in the left ventricle is minimally affected by this procedure.
Statistical Analysis
Previous studies have shown that collateral vessels developed during the period of occlusion, with the bulk of development occurring in the first 3 weeks after surgery. In this model, we have observed many of the pathophysiological responses of the chronically ischemic myocardium. This suggests that collateral development decreases dramatically after the initial early phase, thus resulting in a deficit in coronary reserves. In an effort to develop therapies that accelerate the rate or prolong the period of collateral formation, we have assessed the effect of heparin infusion on collateral growth. Small pumps capable of delivering a continuous dose of heparin were placed in the external jugular vein of animals containing the ameroid constrictor. Heparin was administered continuously from the time of surgery to the time at which the animals were euthanized. These animals are referred to as the heparin-ameroid group. Animals containing the ameroid constrictor but without heparin infusion are referred to as the untreatedameroid group. Normal controls refer to animals that did not undergo surgery and had no interventions. Hemodynamics
Mean aortic blood pressures, heart rates, and left atrial pressures at the time of microsphere blood flow measurements were recorded. In both the untreatedameroid and ameroid-heparin groups, left atrial pressures at 14 days were 17±3 mm Hg; by day 28, the atrial pressures had decreased to a mean of 12±2 mm Hg. Mean aortic blood pressures under resting 'conditions were somewhat low in the 14-and 21-day groups compared with normal controls but increased to normal level by 28 days (Table 1) . During adenosine infusion, mean aortic blood pressures decreased significantly in both groups as expected.
Heart rates were similar in both groups during resting conditions at all time periods and were slightly higher than those of normal controls, perhaps reflecting increased metabolic needs (Table 1) . During adenosine infusion, heart rates tended to decrease slightly, but the changes did not reach significant levels.
Heparin Blood Levels
In swine, heparin has a dose-dependent half-life of about 90 minutes.2930 To assess the level of heparin activity in the experimental animals in this study, we performed the APTT test on the ameroid-control and ameroid-heparin pigs. This test indirectly measures the amount of heparin in the serum by assessing the time required to form blood clots in an in vitro system. 24±0.05 ). These data demonstrate that heparin infusion accelerates the rate at which resting blood flow is restored after coronary artery occlusion and suggests that heparin infusion potentiates the development of collateral vessels. In the heparin-ameroid animals, normal blood levels are regained at or before 14 days after surgery, whereas the untreated-ameroid animals regain normal blood flow levels between 14 and 21 days. The resistance values calculated under resting conditions also support this conclusion.
To evaluate coronary reserve levels, endocardial blood flows and resistances were determined under vasodilated conditions. The animals were given adenosine (1.25 mg . kg.* min-t), which allows for maximal vasodilation27 (also see Fig 1) . In the presence of adenosine, blood pressures were not significantly different among the untreated-ameroid and heparin-ameroid groups compared with the normal controls ( suggesting that collateral development is modulated positively by heparin. In the epicardium (Table 2B) , blood flows values slightly increased compared with normal controls were observed in both the heparin-ameroid and untreatedameroid groups in the left anterior descending region at rest, reflecting differences in metabolic demands. In the left circumflex coronary artery bed at 14 days, the blood flows (1.58±0.11) and resistance values (39±3) for the untreated-ameroid group under vasodilated conditions indicate that the epicardium of these animals was underperfused compared with normal controls. In contrast, in the heparin-ameroid animals at 14 days, blood flows (2.15±0.11) and resistance values (24±2) were not significantly different than normal controls, suggesting that heparin accelerated the growth of collateral vessels in the epicardial region. Midmyocardial blood flows and resistances also were calculated but are not presented; these values were intermediate between the endocardial and the epicardial results.
Collateral-to-Coronary Resistance Ratios
To normalize the effects of the different perfusion pressures during adenosine infusion on blood flow measurements, we calculated the collateral (left circumflex coronary artery)-to-coronary (left anterior descending) resistance ratios from the data in Table 2 (see "Methods" for calculations). Statistical comparisons were made with the values obtained from normal controls. 27 For normal controls, the calculated ratios of left circumflex coronary artery to left anterior descending resistance were 1.02±0.02 (at rest) and 0.98±0.01 (with adenosine) for the endocardium and 1.05±0.04 (at rest) and 1.04±0.03 (with adenosine) for the epicardium. Fig 3 shows resistance ratios for the endocardium and epicardium of the untreated-ameroid and heparinameroid groups under resting and vasodilated conditions. Fig 3A shows that at 14 days, there is a significant difference between the resistance ratios under resting conditions of the untreated-ameroid and the heparinameroid animals. The heparin-treated animals show normal resistance ratios (1.04±0.04) at this early time, indicating that heparin treatment resulted in a rapid return to normal blood flow. In contrast, the left circumflex coronary artery bed in the untreated-ameroid animals is underperfused as indicated by the resistance ratio of 2.13 ±0.23. At 21 and 28 days, the ratios for both groups are close to unity.
During adenosine infusion, the ratio of collateral to coronary resistances represents a measure of coronary collateral reserve.27 As shown in Fig 3B, the high resistance ratios in the untreated-ameroid group indicate diminished coronary collateral reserves. Reserve levels in the untreated-ameroid animals improve over time; however, at 28 days the ratio is still significantly higher (1.62±0.07) than seen in normal controls. Additional measurements made at longer times demonstrate that reserve levels remain below normal even at 4 months after ameroid placement.12,23 Continuous heparin treatment significantly increases the level of coronary reserves at 14 days compared with the untreatedameroid animals, but the heparin group is still underperfused at this early time. Remarkably, by 28 days, the ratio had decreased further to 0.93+0.04, which is not significantly different from normal controls. Table 24 and 2B. Error bars indicate 1 SEM (n=5 to 8). The dotted line indicates the resistance value for normal controls.27 *Significant (P<.05) comparing untreated-ameroid and heparin-ameroid animals at the same time. #Significant (P<.05) comparing either untreated-ameroid or heparin-ameroid animals with normal controls.
As shown in Fig 3C and 3D , the resistance ratios in the epicardium generally are near unity, indicating normal perfusion in this region. However, under vasodilated conditions, the 14-day untreated-ameroid group experienced epicardial underperfusion as indicated by the resistance ratios of 1.74±0.15. By 21 days, the ratios were comparable to those of the normal controls. Infarct Size Fig 4 shows the effect of heparin infusion on infarct sizes. We determined infarct sizes from histology slides by point counting and expressed them as a percentage of the bed at risk. The size of the bed at risk was obtained from weighing the excised, dyed left circumflex coronary artery bed. These bed sizes were 22+1% and 23+1% of the total left ventricular weight in the untreated-ameroid and heparin-ameroid groups, respectively, and there was no difference in bed sizes between the groups. The untreated-ameroid group had infarcts representing 5.8% of the endocardial left circumflex coronary artery bed and 0.8% of the midmyocardial left circumflex coronary artery bed, whereas the heparin- The results presented here indicate that application of an angiogenic agent can profoundly affect the development of blood vessels in the ischemic heart. In the heparin-treated animals, restoration of normal blood flow to the region at risk occurred by (or before) 2 weeks after placement of the ameroid constrictor, whereas normal flow did not return in the untreated animals until 3 weeks. Because 2 weeks was our first time point, it is possible that restoration of blood flow occurred even earlier. Significantly, we also observed rapid and nearly complete recovery of coronary reserves in the heparin-treated animals. In the untreatedameroid group at 28 days, collateral reserve levels were significantly decreased compared with normal controls. In contrast, in the heparin-ameroid group, reserve levels were essentially identical in the normally perfused and collateral-dependent regions during maximum vasodilation (see Fig 3B) . Schaper and coworkers51 have shown that dogs, which generally are considered to be better collateral formers than pigs, do not fully restore reserve levels in the collateral-dependent region. This suggests that heparin administration promoted a remarkable degree of collateral development. In a recent study, we have shown that collateral vessels in the untreated-ameroid group have a significant lack of smooth muscle development, which may influence their capacity to respond to vasodilators.12 In future studies, it will be of interest to determine if the number or composition of the collateral vessels is affected by the heparin treatment.
In this model of gradual coronary artery occlusion, infarct size generally is small, resulting in less than 15% infarction of the left circumflex coronary artery bed. However, we were able to detect a significant decrease in infarct sizes in the heparin-ameroid group. We believe that this is due to the increase in collateral blood flow in the heparin-ameroid group around the time of closure of the left circumflex coronary artery. Alternately, it is possible that heparin inhibited the formation of a thrombus in the constrictor and thereby allowed for more gradual occlusion of the artery. This seems unlikely because thrombotic occlusion generally occurs We had reported previously that heparin did not increase collateral development in pigs with ameroid constrictors. 29 However, in that study, the animals were given heparin twice daily as bolus injections. APTT time measurements, taken at hourly intervals, showed that the serum from heparin-injected animals had 10-to 20-fold increases in clotting times at shortly after heparin administration, but by 3 hours after injection, clotting times had returned to normal (F.C. White Recently, Unger et a122 developed a novel dog model to study collateralization. These investigators implanted the internal mammary artery into the left anterior descending bed and subsequently occluded the left anterior descending, rendering the bed collaterally dependent. Infusion of heparin directly into the implanted artery increased the proportion of blood flow through this vessel approximately 2.5-fold. This localized gain in flow was not due to an increase in the absolute level of collateral flow but rather was achieved by a decrease in flow from other sources, presumably because the endogenous collateral flow was sufficient to meet the requirements of the bed at risk. Therefore, although this study dramatically demonstrates the angiogenic effect of heparin, it also indicates that the enormous potential for collateral growth in the dog makes this species a limited model for human collateral development.
Heparin appears to increase angiogenesis by several mechanisms, one of which involves its interaction with angiogenic growth factors, such as acidic and basic fibroblast growth factors. Heparin protects both these factors from inactivation and potentiates the activity of acidic fibroblast growth factor.35 '36 Heparin also releases basic fibroblast growth factor from the extracellular matrix, thereby making this factor available for interaction with endothelial cells. 37 Recently, it has been shown with circular ameroid occluders and not with oval occluders such as the kind used in our studies.
that cell surface heparinlike molecules are required for the binding of basic fibroblast growth factor38 and vascular endothelial growth factor52 to high-affinity receptors on the cell surface. These authors suggest that heparin, present either as a component of cell surface proteoglycans or free in solution, induces a conformational change in the growth factor that allows it to interact with its receptor. Importantly, angiogenic growth factors have been identified in the ischemic heart as well as in the normal heart. [39] [40] [41] [42] [43] [44] [45] [46] Another mechanism by which heparin may be angiogenic is its ability to increase protease activity. Proteolytic destruction of the extracellular matrix is an important step in the development of new blood vessels. Proteases such as metalloproteases and plasminogen are secreted from sprouting capillary endothelial cells (for a review, see Pepper and Montesano47). Heparin also stimulates the secretion and activation of plasminogen activator. 48, 49 In addition, it recently has been shown that plasminogen activator inhibitor-1 binds to heparin.50 This interaction potentiates the neutralization of plasminogen activator inhibitor-1 by thrombin, thereby favoring proteolysis.
In summary, we have demonstrated that heparin has a dramatic positive effect on the restoration of blood flow within the first 2 weeks after closure. Remarkably, heparin treatment potentiated the complete recovery of reserve levels in the collateral-dependent bed. In addition, the treatment affords the animal significant protection from infarction. This model will be useful in testing the therapeutic value of other angiogenic treatments in the compromised heart and in defining the period most susceptible to such treatments.
